Spectrum Medical
Spectrum Medical is a Hangzhou-based clinical mass spectrometry platform founded in 2020 that develops LC-MS/MS, ICP-MS, GC-MS/MS, and MALDI-TOF instruments under the PreMed brand, serving Chinese hospitals, maternal-child health centers, wellness institutions, and pharmaceutical researchers.
- Company typePrivate
- Founded2020
- HeadquartersHangzhou, China
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Spectrum Medical does
Spectrum Medical (杭州谱聚医疗科技有限公司) is a Hangzhou-based clinical mass spectrometry product platform founded in 2020, though its core R&D team traces back to 2006 and was awarded a National Major Scientific Instrument Development Project grant in 2011. The company develops and manufactures a full line of clinical mass spectrometry instruments under the PreMed brand — LC-MS/MS systems (PreMed 5200, 5300, 5600, PreMed 5000 series), ICP-MS systems (PreMed 7000, 7200), ICP-MS/MS systems (PreMed 7350), GC-MS/MS systems (PreMed 6000), MALDI-TOF Gene TOF systems (PreMed 1000), and automated sample preparation systems (PreMed 3500, 3300). It also offers clinical reagent kits for vitamin, trace element, hormone, amino acid, fatty acid, bile acid, and therapeutic drug monitoring panels. Spectrum Medical claims to be the only company in China with proprietary triple quadrupole mass spectrometry intellectual property and to achieve over 90% domestic component sourcing across its instruments, directly addressing historical Chinese dependence on imported clinical mass spectrometry systems.
The company monetizes through three primary revenue streams: (1) hardware sales of PreMed instruments and sample preparation systems to hospitals, clinical laboratories, and research institutions; (2) recurring revenue from registered and filed clinical reagent kits covering vitamins, trace elements, drug monitoring, and metabolic panels; and (3) professional services including third-party outsourced clinical mass spectrometry testing, laboratory co-construction partnerships with hospitals, and laboratory developed test (LDT) method development. Distribution is sales-led, with direct representatives targeting healthcare providers and on-site service teams providing installation, training, and maintenance. Customer segmentation spans four verticals: hospital clinical laboratories (vitamins, trace elements, hormones, metabolic markers), healthcare and wellness institutions (precision nutrition, chronic disease screening), maternal and child health institutions (newborn genetic metabolic disease screening), and pharmaceutical and research institutions (therapeutic drug monitoring, PK studies).
Spectrum Medical is privately held, headquartered in Hangzhou's Binjiang District with an additional service site in Lin'an District, and currently employs 51–100 people. The company closed a 185 million RMB Series B round led by Sequoia China in June 2022, holds 20+ core patents, operates a 5000+ m² production base with cumulative 1000+ PreMed 7000 ICP-MS shipments, has 30+ approved reagent kits, and has secured ISO 13485 (November 2022), ISO 9001 (June 2022), and National High-Tech Enterprise (January 2024) recognitions. Operations remain domestic-focused across China with no disclosed international footprint.
Spectrum Medical firmographics
Firmographics- Name
- Spectrum Medical
- Legal name
- 杭州谱聚医疗科技有限公司
- Website
- https://expeclin.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Spectrum Medical is a Hangzhou-based clinical mass spectrometry platform founded in 2020 that develops LC-MS/MS, ICP-MS, GC-MS/MS, and MALDI-TOF instruments under the PreMed brand, serving Chinese hospitals, maternal-child health centers, wellness institutions, and pharmaceutical researchers.
- Ownership category
- akta.pro rank
Spectrum Medical industry classification
Industry- Product category
- Clinical Mass Spectrometry Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)
- SIC
- Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Mass Spectrometry & Spectroscopy Instruments (HLAGAIAB)
- akta.pro secondary industries
- Proteomics & Mass Spectrometry Services (HLAGANAB), Analytical Instruments & Chromatography Systems (HLAGAIAA)
Keywords
Where Spectrum Medical is headquartered
LocationHeadquarters
- HQ city
- Hangzhou
- HQ country
- China
- HQ region
- Asia
Offices2 records
Markets served
Spectrum Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Mass Spectrometry Equipment Sales: Sale of clinical mass spectrometry instruments including LC-MS/MS, ICP-MS, GC-MS/MS, and Gene TOF systems along with automated sample preparation systems. Equipment is sold directly to hospitals, clinical laboratories, and research institutions.
- Reagent Kits and Consumables: Sale of clinical mass spectrometry detection reagent kits for vitamins, trace elements, drug monitoring, amino acids, fatty acids, and bile acid profiles. Both registered and filed reagent kits available.
- Third-Party Medical Testing Services: Outsourced clinical mass spectrometry testing services, clinical mass spectrometry laboratory co-construction, and LDT (Laboratory Developed Test) method development services.
- Laboratory Construction and Support Services: Laboratory planning, instrument selection, equipment maintenance, personnel training system construction, and standardized service processes for clinical mass spectrometry labs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | Sales Representative Position |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Spectrum Medical product offering
Product offeringCore offering
Spectrum Medical (杭州谱聚医疗科技有限公司) develops, manufactures, and sells clinical mass spectrometry instrument platforms — LC-MS/MS, ICP-MS, GC-MS/MS, and MALDI-TOF (Gene TOF) systems — together with proprietary in-vitro diagnostic reagent kits and automated sample-preparation workstations. Beyond instruments and consumables, the company operates third-party clinical mass-spec testing services and laboratory co-construction programs for hospitals and medical institutions.
Product overview
谱聚医疗 (Spectrum Medical/PuJu Medical) offers a comprehensive clinical mass spectrometry product portfolio including LC-MS/MS systems (PreMed 5200, PreMed 5600, PreMed 5000 series), ICP-MS systems (PreMed 7000, PreMed 7200), ICP-MS/MS systems (PreMed 7350), GC-MS/MS systems (PreMed 6000), MALDI-TOF systems (PreMed 1000), and automated sample pretreatment systems (PreMed 3500, PreMed 3300). The product line also includes clinical reagent kits for vitamin detection, drug concentration monitoring, amino acid profiles, fatty acid profiles, bile acid profiles, and genetic metabolic disease screening. The company is the only domestic enterprise in China with proprietary intellectual property for triple quadrupole technology, achieving over 90% domestic component localization.
Differentiator
Problem solved
Functional benefit
Brands
- PreMed: 临床质谱设备品牌，包括PreMed 5200、5600、7000、6000、1000、3300、3500等多种型号，覆盖LC-MS/MS、ICP-MS、GC-MS/MS、Gene TOF等质谱平台及全自动样本前处理系统
Products and services
- PreMed 5200 LC-MS/MS Clinical liquid chromatography–tandem mass spectrometry instrument for quantitative in-vitro diagnostic testing in hospital and clinical laboratories.
- PreMed 5600 LC-MS/MS Higher-throughput clinical LC-MS/MS instrument for quantitative in-vitro diagnostic assays such as therapeutic-drug monitoring and hormone profiling.
- PreMed 5000 Series LC-MS/MS Family of clinical LC-MS/MS instruments for routine quantitative in-vitro diagnostic testing in clinical laboratories.
- PreMed 7000 ICP-MS Clinical inductively coupled plasma mass spectrometry instrument for trace-element analysis in clinical samples.
- PreMed 7200 ICP-MS Clinical ICP-MS instrument for quantitative trace-element and metal analysis in clinical diagnostic workflows.
- PreMed 7350 ICP-MS/MS Triple-quadrupole ICP-MS/MS clinical instrument for high-sensitivity trace-element analysis with reduced spectral interference in clinical diagnostics.
- PreMed 6000 GC-MS/MS Clinical gas chromatography–tandem mass spectrometry instrument for volatile and small-molecule clinical assays.
- PreMed 1000 Gene TOF (MALDI-TOF) Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for clinical microbial identification in hospital microbiology laboratories.
- PreMed 3500 Automated Sample Preparation System Automated clinical sample-preparation workstation used upstream of LC-MS/MS and ICP-MS systems to standardize sample handling.
- PreMed 3300 Automated Sample Preparation System Automated sample-preparation workstation for clinical mass-spectrometry workflows.
- Clinical IVD Reagent Kits Proprietary in-vitro diagnostic reagent kits for use on Spectrum Medical's mass spectrometry platforms, covering therapeutic drugs, vitamins (including vitamin D), steroid hormones, and trace elements.
- Third-Party Clinical Mass Spectrometry Testing Services Centralized third-party clinical mass spectrometry testing services offered to hospitals, clinics, and other medical institutions that do not run mass-spec assays in-house.
- Laboratory Co-Construction (Lab Co-Build) Services Partnership program in which Spectrum Medical co-builds and operates clinical mass spectrometry laboratories inside hospitals or healthcare networks, providing instruments, reagents, workflow, and staff training.
Quantifiable outcome
- PreMed 5600 signal intensity improved 10x with 2-8x SNR improvement over PreMed 5200
- +2 more outcomes
Companies that use Spectrum Medical
Customer profileSegments4 records
Ideal customer profiles2 records
Spectrum Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Spectrum Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Chengdu Tianfu International Bio-citycoreSpectrum Medical participated as a strategic partner in the 'Innovation Shapes the Future' Chengdu Tianfu International Bio-city Innovation Ecosystem Forum, engaging with bio-pharmaceutical experts and scholars on industry ecosystem development.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Spectrum Medical competitors and assessment
Company assessmentBroad incumbents
- SCIEX (Danaher): SCIEX, a Danaher operating company, is a global leader in mass spectrometry with a deeply entrenched clinical LC-MS/MS installed base; the closest global incumbent peer to Spectrum Medical's PreMed LC-MS/MS and triple-quadrupole systems.
- Agilent Technologies: Agilent is a global analytical instrument leader with strong LC-MS/MS, GC-MS/MS, and ICP-MS product lines competing for the same hospital and clinical laboratory customers as Spectrum Medical.
- Waters Corporation: Waters is a global mass spectrometry leader with deep penetration in clinical and biomedical research laboratories, offering LC-MS/MS and ion-mobility systems directly comparable to Spectrum Medical's PreMed platform.
- Shimadzu: Shimadzu offers a broad mass spectrometry portfolio (LC-MS/MS, GC-MS/MS, ICP-MS) widely deployed across Asian clinical laboratories, making it a direct competitor to Spectrum Medical's PreMed series in the Chinese market.
- Thermo Fisher Scientific: Thermo Fisher operates one of the world's largest analytical instrument businesses including clinical mass spectrometry; its scale, service network, and reagent ecosystem are a structural benchmark for Spectrum Medical's ambitions.
- Bruker: Bruker is a global mass spectrometry and MALDI-TOF leader; its clinical microbiology and nucleic-acid mass spec systems overlap with Spectrum Medical's PreMed 1000 Gene TOF platform.
- Mindray Medical (迈瑞医疗): Mindray is China's largest domestic medical device company with a broad IVD portfolio; while not primarily a mass spectrometry vendor, it is a potential adjacent competitor as it expands into higher-end clinical diagnostics in Chinese hospitals.
Direct peers
- Calibra Diagnostics (凯莱谱): Calibra Diagnostics is a Chinese clinical mass spectrometry startup that builds LC-MS/MS platforms and IVD reagent kits for therapeutic drug monitoring — directly competing with Spectrum Medical in the same Chinese clinical mass spec niche.
- Dian Diagnostics (迪安诊断): Dian Diagnostics operates one of China's largest independent medical laboratory networks; its third-party clinical testing and lab-co-construction services directly compete with Spectrum Medical's testing and lab-services revenue streams.
Regional players
- Autobio Diagnostics (安图生物): Autobio is a leading Chinese IVD and immunoassay company that serves similar hospital clinical laboratory customers and could expand into the clinical mass spectrometry segment Spectrum Medical targets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Spectrum Medical compliance and trust
Trust signalCompliance2 records
Spectrum Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Spectrum Medical leadership team
Management profileNumber of profiles
Spectrum Medical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Spectrum Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Spectrum Medical
What does Spectrum Medical do?
Spectrum Medical (杭州谱聚医疗科技有限公司) develops, manufactures, and sells clinical mass spectrometry instrument platforms — LC-MS/MS, ICP-MS, GC-MS/MS, and MALDI-TOF (Gene TOF) systems — together with proprietary in-vitro diagnostic reagent kits and automated sample-preparation workstations. Beyond instruments and consumables, the company operates third-party clinical mass-spec testing services and laboratory co-construction programs for hospitals and medical institutions.
Is Spectrum Medical a public or private company?
Spectrum Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Spectrum Medical founded?
Spectrum Medical was founded in 2020. It employs 51 to 100 people.
Where is Spectrum Medical based?
Spectrum Medical is headquartered in Hangzhou, China, in the Asia region.
How does Spectrum Medical make money?
Four revenue lines are on record. Mass Spectrometry Equipment Sales are the primary driver. The others are reagent Kits and Consumables, third-Party Medical Testing Services and laboratory Construction and Support Services.
Who are Spectrum Medical's main competitors?
Broad incumbents on record are SCIEX (Danaher), Agilent Technologies, Waters Corporation, Shimadzu, Thermo Fisher Scientific, Bruker and Mindray Medical (迈瑞医疗). Direct peers are Calibra Diagnostics (凯莱谱) and Dian Diagnostics (迪安诊断). Autobio Diagnostics (安图生物) is listed as a regional player.
Does Spectrum Medical have an API?
No public API is recorded for Spectrum Medical.
What industry is Spectrum Medical in?
Spectrum Medical's product category is Clinical Mass Spectrometry Instruments. Its primary akta.pro industry code is HLAGAIAB, Mass Spectrometry & Spectroscopy Instruments, with a secondary code of HLAGANAB, Proteomics & Mass Spectrometry Services. Its NAICS code is 334516 and its SIC code is 3826.